GEOID study
Phase 2
- Conditions
- stomach cancer
- Registration Number
- JPRN-jRCTs051220096
- Lead Sponsor
- Suzuka Takanori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
1) Patients scheduled laparoscopic or robot-assisted gastrectomy at Nara Medical University Hospital
2) ASA physical status 1 or 2
3) Patients aged 20 or over but under 85
4) Patients who signed the informed consent for this study
Exclusion Criteria
1) Patients undergoing temporary surgery who apply on the same day
2) Chronic opioid use
3) Allergy to local anesthetics
4) Communication difficulty
5) Coagulation disorder
6) Patients who weigh under 34kg
7) Patients who have received antithrombotic therapy and conflict with a sufficient period of drug withdrawal according to the guideline published by JSA/JSRA/JSPC
8) Patients who have been judged inappropriate in the study by the investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umerical rating scale (NRS) at 12 hours after surgery
- Secondary Outcome Measures
Name Time Method 1) Numerical rating scale (NRS) at 2 hours, 1 day, and 2 days after surgery <br>2) Fentanyl consumption after surgery<br>3) Quality of Recovery score-15(QoR-15) <br>4) WHODAS 2.0 (WHO disability assessme nt schedule)